Benet Pera

THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors

Florencia Cayrol, Pannee Praditsuktavorn, Tharu M. Fernando et al. · Nature Communications · 2017 · 111 citations · Full text

Medicine, Cancer Biology, Oncology +13

Zampanolide, a Potent New Microtubule-Stabilizing Agent, Covalently Reacts with the Taxane Luminal Site in Tubulin α,β-Heterodimers and Microtubules

Jessica J. Field, Benet Pera, Enrique Calvo et al. · Chemistry & Biology · 2012 · 85 citations · Full text

Life Sciences, Cell Biology, Medicinal Chemistry +14

New Interfacial Microtubule Inhibitors of Marine Origin, PM050489/PM060184, with Potent Antitumor Activity and a Distinct Mechanism

Benet Pera, Isabel Barasoaı́n, Areti Pantazopoulou et al. · ACS Chemical Biology · 2013 · 59 citations

Medicine, Medicinal Chemistry, Pharmacology +17

PM060184, a new tubulin binding agent with potent antitumor activity including P-glycoprotein over-expressing tumors

Marta Martínez, María José Guillen-Navarro, Benet Pera et al. · Biochemical Pharmacology · 2014 · 55 citations

Medicine, Oncology, Pharmacology +11

Combinatorial epigenetic therapy in diffuse large B cell lymphoma pre-clinical models and patients

Benet Pera, Tiffany Tang, Rossella Marullo et al. · Clinical Epigenetics · 2016 · 50 citations · Full text

Medicine, Oncology, Pharmacology +17